X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

ACOR

Closed

Acorda Therapeutics Inc

0.44
+0.44 (0%)
Last Update: 10 May 2024 16:30:00
Yesterday: 0.
Day's Range: 0.4 - 0.68
Send
When Written:
 
0.57
Acorda Therapeutics Inc. is a biopharmaceutical company that focuses on developing therapies to treat neurological disorders. The company was founded in 1995 and is headquartered in Ardsley, New York. Acorda's primary product is Ampyra, which is marketed in the United States as a treatment for multiple sclerosis. The company also has several other products in its pipeline, including treatments for Parkinson's disease and spinal cord injury. Acorda has partnerships with several pharmaceutical companies and academic institutions to advance its research and development efforts. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol ACOR.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X